$128 Million is the total value of M28 Capital Management LP's 12 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | ADAGIO THERAPEUTICS INC | $41,130,000 | – | 5,665,221 | +100.0% | 32.12% | – | |
| STOK | New | STOKE THERAPEUTICS INC | $12,646,000 | – | 527,150 | +100.0% | 9.88% | – |
| CRIS | New | CURIS INC | $12,418,000 | – | 2,608,851 | +100.0% | 9.70% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $11,824,000 | – | 3,765,588 | +100.0% | 9.23% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $10,812,000 | – | 495,280 | +100.0% | 8.44% | – |
| TGTX | New | TG THERAPEUTICS INC | $10,013,000 | – | 527,000 | +100.0% | 7.82% | – |
| BBIO | New | BRIDGEBIO PHARMA INC | $7,776,000 | – | 466,200 | +100.0% | 6.07% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $7,574,000 | – | 560,600 | +100.0% | 5.91% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $7,200,000 | – | 456,865 | +100.0% | 5.62% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $3,240,000 | – | 1,000,000 | +100.0% | 2.53% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,816,000 | – | 19,200 | +100.0% | 2.20% | – |
| NEXI | New | NEXIMMUNE INC | $615,000 | – | 133,442 | +100.0% | 0.48% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-11
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| WAVE LIFE SCIENCES LTD | 8 | Q3 2023 | 46.4% |
| INVIVYD INC | 8 | Q3 2023 | 32.1% |
| ROCKET PHARMACEUTICALS INC | 8 | Q3 2023 | 16.6% |
| BRIDGEBIO PHARMA INC | 8 | Q3 2023 | 6.1% |
| TG THERAPEUTICS INC | 8 | Q3 2023 | 9.2% |
| NEXIMMUNE INC | 8 | Q3 2023 | 0.5% |
| STOKE THERAPEUTICS INC | 7 | Q2 2023 | 10.2% |
| CURIS INC | 7 | Q2 2023 | 9.7% |
| PROQR THRAPEUTICS N V | 7 | Q3 2023 | 6.7% |
| ATARA BIOTHERAPEUTICS INC | 5 | Q1 2023 | 5.6% |
View M28 Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adagio Therapeutics, Inc. | August 19, 2022 | 9,248,250 | 8.5% |
View M28 Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-05-25 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-10 |
View M28 Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.